Kymera Therapeutics, Inc.KYMRNASDAQ
LOADING
|||
EV to Sales: Discounted Valuation
Trending higher, below historical average.
Left:
||||
Enterprise value to sales ratio
Latest
63.45
↓ 38% below average
Average (6y)
102.57
Historical baseline
Range
High:486.10
Low:0.00
Volatility
473.9%
High variability
| Period | Value | Change |
|---|---|---|
| 2024 | 63.45 | +241.4% |
| 2023 | 18.59 | -32.8% |
| 2022 | 27.66 | -33.2% |
| 2021 | 41.42 | -48.7% |
| 2020 | 80.79 | -83.4% |
| 2019 | 486.10 | - |
| 2018 | 0.00 | - |